Forendo Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $955M

Forendo Pharma General Information

Description

Developer of therapeutic drugs designed to assist in the treatment of women's health indications. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions like endometriotic lesions and polycystic ovarian syndrome, enabling medical professionals to improve the treatment of female urological conditions.

Contact Information

Website
www.forendo.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Itäinen Pitkäkatu 4 B
  • 20520 Turku
  • Finland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Itäinen Pitkäkatu 4 B
  • 20520 Turku
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forendo Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-Dec-2021 $955M Completed Clinical Trials - Phase 1
7. Later Stage VC 03-Dec-2019 Completed Clinical Trials - Phase 1
6. Later Stage VC 17-Jul-2019 Completed Clinical Trials - Phase 1
5. Later Stage VC 05-Sep-2018 Completed Clinical Trials - Phase 1
4. Debt - General 19-Mar-2018 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 23-Oct-2014 Completed Startup
2. Debt - General 01-Jan-2014 $4.59M Completed Startup
1. Seed Round 01-Jan-2013 $4.59M $4.59M Completed Startup
To view Forendo Pharma’s complete valuation and funding history, request access »

Forendo Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B1 shares
B1 shares
B1 shares
Series B 2,083 $3340.7 $3340.7 1x $3340.7 13.84%
Series B 2,435 $1587.65 $1587.65 1x $1587.65 13.84%
To view Forendo Pharma’s complete cap table history, request access »

Forendo Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic drugs designed to assist in the treatment of women's health indications. The company's drugs ar
Drug Discovery
Turku, Finland
24 As of 2022

Stevenage, United Kingdom
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Forendo Pharma Competitors (70)

One of Forendo Pharma’s 70 competitors is NeRRe Therapeutics, a Venture Capital-Backed company based in Stevenage, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeRRe Therapeutics Venture Capital-Backed Stevenage, United Kingdom
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Meditope Biosciences Formerly VC-backed Pasadena, CA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Minerva Neurosciences Formerly VC-backed Burlington, MA
You’re viewing 5 of 70 competitors. Get the full list »

Forendo Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forendo Pharma Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Finnvera Lender/Debt Provider Minority
Innovestor Venture Capital Minority
KDventures Venture Capital Minority
M Ventures Corporate Venture Capital Minority
Novartis Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Forendo Pharma FAQs

  • When was Forendo Pharma founded?

    Forendo Pharma was founded in 2013.

  • Where is Forendo Pharma headquartered?

    Forendo Pharma is headquartered in Turku, Finland.

  • What is the size of Forendo Pharma?

    Forendo Pharma has 24 total employees.

  • What industry is Forendo Pharma in?

    Forendo Pharma’s primary industry is Drug Discovery.

  • Is Forendo Pharma a private or public company?

    Forendo Pharma is a Private company.

  • What is the current valuation of Forendo Pharma?

    The current valuation of Forendo Pharma is .

  • What is Forendo Pharma’s current revenue?

    The current revenue for Forendo Pharma is .

  • How much funding has Forendo Pharma raised over time?

    Forendo Pharma has raised $36.7M.

  • Who are Forendo Pharma’s investors?

    Finnvera, Innovestor, KDventures, M Ventures, and Novartis are 5 of 9 investors who have invested in Forendo Pharma.

  • Who are Forendo Pharma’s competitors?

    NeRRe Therapeutics, Inovio Pharmaceuticals, Meditope Biosciences, Sangamo Therapeutics, and Minerva Neurosciences are some of the 70 competitors of Forendo Pharma.

  • When was Forendo Pharma acquired?

    Forendo Pharma was acquired on 13-Dec-2021.

  • Who acquired Forendo Pharma?

    Forendo Pharma was acquired by Organon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process